A recent post hoc analysis assesses whether PSA changes can predict survival outcomes in patients with metastatic or very high risk nonmetastatic prostate cancer.
Prostate-specific antigen (PSA) blood testing likely reduces the risk of death from prostate cancer, found a new review ...
A new blood test could help doctors identify whether a treatment for advanced prostate cancer is failing weeks earlier than ...
If it wasn’t for a chance encounter at a coffee shop in Almonte 25 years ago, Terry Cairns thinks he wouldn’t be alive today ...
A new comprehensive review suggests that screening men for prostate cancer using a blood test could reduce deaths from the ...
A major review of nearly 800,000 men has found prostate cancer screening using a specific test is likely to reduce deaths ...
Novartis today announced new data from PSMAddition demonstrating improved prostate-specific antigen (PSA) responses with ...
Patented Algorithm Designed to Help Identify Otherwise Dangerous Prostate Tumors Earlier Using Repeat Blood Test ResultsLicensing Agreement ...
Prostate cancer screening likely to reduce deaths but experts remain uncertain due to possible risks
The number of deaths from prostate cancer is likely to be reduced thanks to screening for the disease, but experts have ...
A groundbreaking blood test could enable doctors to identify failing prostate cancer treatment earlier, a trial found.
A man diagnosed with stage four prostate cancer after having a swollen knee says he does not know how long he has left and is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results